Specific immune therapy-related cutaneous B-cell pseudolymphoma with following dissemination

[B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy].

Aluminium hydroxide is used as an adjuvant in vaccines. We describe the case of a patient who presented a persistent adverse local reaction to aluminium hydroxide due to hyposensitization therapy to dust mites. Multiple painful and pruriginous subcutaneous nodules were observed in both arms, along with hypertrichosis at the injection site. Histology revealed a pseudolymphomatous B cell reaction...

Cutaneous pseudolymphoma following administration of lornoxicam.

Cutaneous B-Cell Pseudolymphoma: Report of Two Cases

erogeneous group of benign reactive T or B cell lymphoproliferative disease of the skin. Cutaneous B cell pseudolymphoma (CBPL) shares many histopathologic and clinical features with cutaneous B cell lymphoma. Therefore, it is often impossible for the dermatologists to make a conclusive diagnosis of CBPL. Recently, Immunoglobulin gene rearrangement using polymerase chain reaction (PCR) or south...

Diffuse cutaneous pseudolymphoma due to therapy with medicinal leeches.

Report of aCase |Awomanonher50spresentedwitha6-month historyofmultiple, firm, reddish, pruritic andexcoriatedpapulesandnodulesextensivelydistributedontheback (Figure 1). The patient was otherwise healthy, with a medical history of only fibromyalgia, andbothclinical examinationandbloodtest findings were unremarkable. Histologic examination of 2 punch biopsy specimens taken from the nodules on th...

Primary cutaneous precursor B-cell lymphoblastic lymphoma with late dissemination.

A 20-year-old woman presented with multiple painless nodular swellings on the skin of the extremities and face, without any systemic symptoms. Biopsy with immunohistochemistry revealed a diagnosis of precursor B-cell lymphoblastic lymphoma. There was no extracutaneous site of involvement. The patient denied chemotherapy and was subsequently lost to follow-up. She presented with symptomatic diss...